Schneider LS - Search Results

1

Psychosis of Alzheimer's disease: clinical characteristics and history.

Schneider LS, Dagerman KS. Schneider LS, et al. J Psychiatr Res. 2004 Jan;38(1):105-11. doi: 10.1016/s0022-3956(03)00092-x. J Psychiatr Res. 2004. PMID: 14690773 Review.

2

Increasing ethnic minority participation in Alzheimer disease research.

Olin JT, Dagerman KS, Fox LS, Bowers B, Schneider LS. Olin JT, et al. Among authors: schneider ls. Alzheimer Dis Assoc Disord. 2002;16 Suppl 2:S82-5. doi: 10.1097/00002093-200200002-00009. Alzheimer Dis Assoc Disord. 2002. PMID: 12351920 Review.

3

Psychosis of Alzheimer disease: validity of the construct and response to risperidone.

Schneider LS, Katz IR, Park S, Napolitano J, Martinez RA, Azen SP. Schneider LS, et al. Am J Geriatr Psychiatry. 2003 Jul-Aug;11(4):414-25. Am J Geriatr Psychiatry. 2003. PMID: 12837670 Clinical Trial.

4

Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.

Schneider LS, Ismail MS, Dagerman K, Davis S, Olin J, McManus D, Pfeiffer E, Ryan JM, Sultzer DL, Tariot PN. Schneider LS, et al. Schizophr Bull. 2003;29(1):57-72. doi: 10.1093/oxfordjournals.schbul.a006991. Schizophr Bull. 2003. PMID: 12908661

5

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Schneider LS, Dagerman KS, Insel P. Schneider LS, et al. JAMA. 2005 Oct 19;294(15):1934-43. doi: 10.1001/jama.294.15.1934. JAMA. 2005. PMID: 16234500

6

Drug development, clinical trials, cultural heterogeneity in Alzheimer disease: the need for pro-active recruitment.

Schneider LS. Schneider LS. Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):279-83. doi: 10.1097/01.wad.0000190808.97878.b8. Alzheimer Dis Assoc Disord. 2005. PMID: 16327360 Review.

7

A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

Schneider LS, DeKosky ST, Farlow MR, Tariot PN, Hoerr R, Kieser M. Schneider LS, et al. Curr Alzheimer Res. 2005 Dec;2(5):541-51. doi: 10.2174/156720505774932287. Curr Alzheimer Res. 2005. PMID: 16375657 Clinical Trial.

8

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Schneider LS, Dagerman K, Insel PS. Schneider LS, et al. Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210. doi: 10.1097/01.JGP.0000200589.01396.6d. Am J Geriatr Psychiatry. 2006. PMID: 16505124

9

Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial.

Mintzer J, Greenspan A, Caers I, Van Hove I, Kushner S, Weiner M, Gharabawi G, Schneider LS. Mintzer J, et al. Among authors: schneider ls. Am J Geriatr Psychiatry. 2006 Mar;14(3):280-91. doi: 10.1097/01.JGP.0000194643.63245.8c. Am J Geriatr Psychiatry. 2006. PMID: 16505133 Clinical Trial.

10

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA; CATIE-AD Study Group. Schneider LS, et al. N Engl J Med. 2006 Oct 12;355(15):1525-38. doi: 10.1056/NEJMoa061240. N Engl J Med. 2006. PMID: 17035647 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters